NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,450,536 | -23.6% | 443,133 | -0.2% | 0.07% | -21.1% |
Q2 2023 | $7,136,542 | +527.7% | 444,091 | +1232.3% | 0.09% | +650.0% |
Q4 2021 | $1,137,000 | -97.2% | 33,333 | -96.0% | 0.01% | -97.5% |
Q3 2021 | $40,118,000 | +57.6% | 831,629 | +47.5% | 0.48% | +41.2% |
Q2 2021 | $25,462,000 | -20.3% | 563,696 | -14.9% | 0.34% | -28.5% |
Q1 2021 | $31,938,000 | +10.5% | 662,194 | +23.4% | 0.47% | +0.9% |
Q4 2020 | $28,898,000 | +34.4% | 536,742 | -7.9% | 0.47% | +5.7% |
Q3 2020 | $21,509,000 | +18.2% | 583,057 | -0.7% | 0.44% | -0.2% |
Q2 2020 | $18,194,000 | -17.4% | 587,293 | -26.4% | 0.44% | -39.8% |
Q1 2020 | $22,023,000 | +8.4% | 797,643 | +14.8% | 0.74% | +36.3% |
Q4 2019 | $20,323,000 | +136.2% | 694,800 | +54.4% | 0.54% | +92.9% |
Q3 2019 | $8,603,000 | -57.0% | 449,928 | -50.7% | 0.28% | -55.3% |
Q2 2019 | $20,017,000 | +30.5% | 912,338 | +21.7% | 0.63% | +8.9% |
Q1 2019 | $15,334,000 | +60.8% | 749,450 | -0.9% | 0.58% | +41.2% |
Q4 2018 | $9,537,000 | +61.6% | 756,327 | +42.6% | 0.41% | +77.4% |
Q3 2017 | $5,903,000 | +31.9% | 530,371 | +6.1% | 0.23% | +39.4% |
Q2 2017 | $4,477,000 | -60.2% | 499,689 | -64.9% | 0.16% | -57.1% |
Q1 2017 | $11,242,000 | -26.7% | 1,424,862 | -20.3% | 0.38% | -29.0% |
Q4 2016 | $15,328,000 | +0.4% | 1,788,560 | -3.7% | 0.54% | +5.0% |
Q3 2016 | $15,273,000 | +4.5% | 1,857,989 | +2.2% | 0.52% | -1.0% |
Q2 2016 | $14,613,000 | +13.0% | 1,817,500 | -5.3% | 0.52% | +24.3% |
Q1 2016 | $12,936,000 | -18.2% | 1,919,299 | -4.5% | 0.42% | -21.4% |
Q4 2015 | $15,817,000 | +58.4% | 2,009,772 | +15.4% | 0.53% | +48.1% |
Q3 2015 | $9,983,000 | +14.4% | 1,742,194 | +8.0% | 0.36% | +19.2% |
Q2 2015 | $8,726,000 | +21.7% | 1,612,936 | +5.1% | 0.30% | +21.8% |
Q1 2015 | $7,168,000 | +6.0% | 1,534,922 | -5.4% | 0.25% | -8.8% |
Q4 2014 | $6,764,000 | -33.0% | 1,621,999 | -16.3% | 0.27% | -29.4% |
Q3 2014 | $10,098,000 | – | 1,938,213 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |